Sponsor:
Children's Hospital of Philadelphia
Code:
NCT06839456
Conditions
Leukemia
High Risk Acute Lymphoblastic Leukemia
High Risk Acute Myeloid Leukemia
Relapse Leukemia
MDS (Myelodysplastic Syndrome)
Eligibility Criteria
Sex: All
Age: 1 - 25
Healthy Volunteers: Not accepted
Interventions
Phase 1 Dose Level 1
Phase 1 Dose Level 2
Phase 1 Dose Level 3
Phase 2 Maximum Tolerated Dose determined in Phase 1
Phase 2 Established Dose from prior study, NCT03810196
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-19. This information was provided to ClinicalTrials.gov by Children's Hospital of Philadelphia on 2025-03-25.